MoneyWorks4Me

Piramal Pharma - Quaterly Results

28 Jul 2025 Evaluate
The sales is pegged at Rs. 9698.80 millions for the June 2025 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 10632.00 millions during the year-ago period.A good growth in profit of 32.68% reported to Rs. 1131.40  millions over Rs. 852.70 millions of corresponding previous quarter.Operating profit for the quarter ended June 2025 rose to 2252.50 millions as compared to 1883.90 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 9698.80 10632.00 -8.78 9698.80 10632.00 -8.78 52857.10 43901.10 20.40
Other Income 1809.20 367.60 392.17 1809.20 367.60 392.17 2073.50 2020.60 2.62
PBIDT 2252.50 1883.90 19.57 2252.50 1883.90 19.57 12477.90 8199.80 52.17
Interest 232.30 248.80 -6.63 232.30 248.80 -6.63 1145.60 1071.00 6.97
PBDT 2020.20 1635.10 23.55 2020.20 1635.10 23.55 11332.30 7128.80 58.97
Depreciation 594.40 518.50 14.64 594.40 518.50 14.64 2220.90 2052.60 8.20
PBT 1425.80 1116.60 27.69 1425.80 1116.60 27.69 9111.40 5076.20 79.49
TAX 294.40 263.90 11.56 294.40 263.90 11.56 2197.40 1164.00 88.78
Deferred Tax 98.10 -10.40 -1043.27 98.10 -10.40 -1043.27 203.00 39.20 417.86
PAT 1131.40 852.70 32.68 1131.40 852.70 32.68 6914.00 3912.20 76.73
Equity 13248.20 13229.50 0.14 13248.20 13229.50 0.14 13243.50 13229.50 0.11
PBIDTM(%) 23.22 17.72 31.07 23.22 17.72 31.07 23.61 18.68 26.39
Peers
Company Name CMP
Sun Pharma. Inds. 1846.80
Dr. Reddys Labs. 1228.60
Cipla 1390.60
Lupin 2069.80
Zydus Lifesciences 1216.00
View more..